• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

    11/14/22 4:08:50 PM ET
    $BBLN
    Medical/Nursing Services
    Health Care
    Get the next $BBLN alert in real time by email
    SC 13G/A 1 tm2230228d1_sc13ga.htm SC 13G/A

     

      

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549  

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

     

    Babylon Holdings Limited

    (Name of Issuer)

     

    Class A ordinary shares, $0.0000422573245084686 par value per share

    (Title of Class of Securities)

     

    G07031 100

    (CUSIP Number)

     

    November 3, 2022

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ¨ Rule 13d-1(b)
    x Rule 13d-1(c)
    ¨ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. G07031 100
     
      1. Names of Reporting Persons
    The Public Investment Fund
     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ¨
        (b) ¨
     
      3. SEC Use Only
     
      4. Citizenship or Place of Organization
    Kingdom of Saudi Arabia
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    75,769,746
     
    6. Shared Voting Power
    0
     
    7. Sole Dispositive Power
    75,769,746
     
    8. Shared Dispositive Power
    0
     
      9. Aggregate Amount Beneficially Owned by Each Reporting Person
    75,769,746
     
      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
      11. Percent of Class Represented by Amount in Row (9)
    12.3%(1)
     
      12. Type of Reporting Person (See Instructions)
    OO
               
    (1)Based on a total of 616,425,986 Class A ordinary shares, $0.0000422573245084686 par value per share (“Class A ordinary shares”), of Babylon Holdings Limited (the “Issuer”), which includes (1) 346,863,905 Class A ordinary shares, outstanding as of October 11, 2022, as disclosed in Exhibit 10.1 to the Issuer’s Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on October 18, 2022, (2) 189,924,505 Class A ordinary shares (prior to rounding of fractional shares) issued in a private placement by the Issuer to certain investors, including the Reporting Person, on November 3, 2022 and (3) 79,637,576 Class A ordinary shares issued in a conversion of all of the outstanding 79,637,576 Class B ordinary shares, $0.0000422573245084686 par value per share, on a one-for-one basis on November 3, 2022.

     

     

     

     

    Item 1.
      (a) Name of Issuer
    Babylon Holdings Limited
      (b) Address of Issuer’s Principal Executive Offices
    1 Knightsbridge Green, London, SW1X 7QA, United Kingdom
     
    Item 2.
      (a) Name of Person Filing
    The Public Investment Fund
      (b) Address of Principal Business Office or, if none, Residence
    The Public Investment Fund, P.O. Box 6847, Riyadh 11452, Kingdom of Saudi Arabia  
      (c) Citizenship
    The Public Investment Fund – Kingdom of Saudi Arabia
      (d) Title of Class of Securities
    Class A ordinary shares, $0.0000422573245084686 par value per share
      (e) CUSIP Number
    G07031 100
     
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) ¨ A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);
      (k) ¨

    Group, in accordance with § 240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with

    § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:____________________________

     

    Item 4. Ownership
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
      (a) Amount beneficially owned:
    The Public Investment Fund – 75,769,746  
      (b) Percent of class:
    The Public Investment Fund – 12.3%  
      (c) Number of shares as to which the person has:      
         
        (i) Sole power to vote or to direct the vote
    The Public Investment Fund – 75,769,746  
        (ii) Shared power to vote or to direct the vote
    The Public Investment Fund – 0  
        (iii) Sole power to dispose or to direct the disposition of
    The Public Investment Fund – 75,769,746  
        (iv) Shared power to dispose or to direct the disposition of  
    The Public Investment Fund – 0  

     

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ¨.
     
    Item 6. Ownership of More than Five Percent on Behalf of Another Person
    Not applicable.
     
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
    Not applicable.
     
    Item 8. Identification and Classification of Members of the Group
    Not applicable.
     
    Item 9. Notice of Dissolution of Group
    Not applicable.

     

    Item 10. Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

    Signature

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: November 14, 2022

     

      THE PUBLIC INVESTMENT FUND
         
      By: /s/ Turqi A. Alnowaiser
         
      Name: Turqi A. Alnowaiser
         
      Title Deputy Governor and Head of International Investments

     

     

      ATTENTION  
    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

     

     

    Get the next $BBLN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BBLN

    DatePrice TargetRatingAnalyst
    3/16/2023Buy → Neutral
    BTIG Research
    1/5/2023$4.00 → $20.00Buy
    BTIG Research
    6/23/2022$2.00Neutral
    BofA Securities
    4/28/2022$5.50Hold
    Berenberg
    1/12/2022$9.00Buy
    Deutsche Bank
    12/7/2021$8.00Neutral
    Citigroup
    12/2/2021$14.00Buy
    Canaccord Genuity
    12/2/2021$9.00Hold
    Jefferies
    More analyst ratings

    $BBLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Babylon downgraded by BTIG Research

      BTIG Research downgraded Babylon from Buy to Neutral

      3/16/23 7:14:08 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BTIG Research reiterated coverage on Babylon with a new price target

      BTIG Research reiterated coverage of Babylon with a rating of Buy and set a new price target of $20.00 from $4.00 previously

      1/5/23 9:37:21 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BofA Securities initiated coverage on Babylon with a new price target

      BofA Securities initiated coverage of Babylon with a rating of Neutral and set a new price target of $2.00

      6/23/22 9:05:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Babylon Proceeds With Previously Announced Transaction and Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

      Babylon Holdings Limited (the "Company" or "Babylon") (NYSE:BBLN) previously announced in its June 23, 2023 press release that the Company has received a proposal from AlbaCore Capital LLP ("AlbaCore") and MindMaze Group SA ("MindMaze") pursuant to which core operating subsidiaries of the Company would be transferred to MindMaze (the "Proposed Transaction"). The closing of the Proposed Transaction is expected in July 2023 and is subject to agreed documentation, various conditions and appropriate approvals, if required. The Proposed Transaction will not provide for any payment to the Company's Class A ordinary shareholders or other equity instrument holders, as AlbaCore will be exercising ri

      6/28/23 4:30:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces Update on Take Private Proposal

      After a thorough exploration of strategic alternatives, Babylon Holdings Limited (NYSE:BBLN) (including its subsidiaries, "Babylon") is pleased to provide an update on the recapitalization transaction, previously announced on May 10, following receipt of a proposal from AlbaCore Capital LLP on behalf of certain of its affiliates ("AlbaCore") and MindMaze Group SA ("MindMaze"), and share that Babylon has selected the previously announced take private proposal from the options considered. The proposal strongly positions Babylon to accelerate its core mission – to make high quality healthcare more accessible and affordable by combining the most cutting-edge technology with the best medical ex

      6/23/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    SEC Filings

    See more
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/31/23 5:18:08 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/11/23 5:01:17 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form NT 10-Q filed by Babylon Holdings Limited

      NT 10-Q - Babylon Holdings Ltd (0001866390) (Filer)

      8/10/23 5:21:19 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Financials

    Live finance-specific insights

    See more
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces First Quarter 2023 Earnings Conference Call

      Babylon (NYSE:BBLN) (the "Company") today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May 10, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instant telephone access to the event, w

      4/19/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Another Strong Year Exceeding Guidance, and Accelerates Expected Adjusted EBITDA Profitability to Mid-2024

      Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable1, with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins2 in their first year Monthly Adjusted EBITDA of $(16.3) million for Q4 2022 beating guidance of $(18) million Adjusted EBITDA profitability expected in mid-2024, significantly earlier than previous guidance Commercial VBC revenue substantially increased with recent launch of Ambetter digital-first service across 6 states Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial an

      3/9/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/30/23 4:18:26 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/28/23 5:29:39 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv (Cyprus) Ltd

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/26/23 6:25:34 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Leadership Updates

    Live Leadership Updates

    See more
    • Babylon Appoints David Humphreys as Chief Financial Officer

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company"), one of the world's fastest growing digital healthcare companies, announces that David Humphreys will be appointed as the Company's new Chief Financial Officer. Mr. Humphreys has been at Babylon for nearly two years in the role of Finance Director, with overall responsibility for building and scaling Babylon's finance function. Formerly, he was US-based as a Silicon Valley and New York Partner with PwC for over 20 years, working with Boards and leaders of fast-moving, rapid-growth companies including Tesla and Facebook to which he provided accounting consulting, transaction, IPO, M&A and auditing services to ensure complianc

      8/23/22 5:10:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)

      SC 13D/A - Babylon Holdings Ltd (0001866390) (Subject)

      6/29/23 5:26:01 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      2/14/23 11:54:33 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      11/14/22 4:08:50 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care